Boehringer Ingelheim stroke website Background   Stroke / TIA facts       Stroke Morbidity and Morality       Cost of Stroke   Prevalence / Incidence   Pathogenesis / Pathophysiology       Stroke Subtypes       Pathogenesis of Ischaemic Stroke       Pathogenic Process of Ischaemic Stroke   Symptoms & Diagnostic Procedures       Transient Ischaemic Attack (TIA) & Stroke       Diagnostic Procedures   Risk Factors   Treatment   Guidelines       Acute Treatment Guidelines       Secondary Prevention Guidelines       References to Guidelines   Acute Treatment       Emergency Medical Service       General Stroke Therapy       Acute Antithrombotic Treatment       Thrombolytic Therapy       Secondary Complications   Secondary Stroke Prevention       Aspirin and Dipyridamole       Clopidogrel in the Secondary Prevention   Our Products   Actilyse®   Aggrenox®   Symposia & Congresses   Calender   Virtual Symposia       Events       Topics       Speakers   Associations   Studies & Publications   Acute Treatment       Publications       Streptokinase Studies       ATLANTIS       NINDS       ECASS 1       ECASS 2       ECASS 3       Combined Analysis       PROACT II       SITS-MOST       CASES   Secondary Prevention       PRoFESS       ONTARGET / TRANSCEND       ESPS I       ESPS II       ESPS II Reanalysis       ESPRIT       CARDIAC SAFETY       MATCH       Bioavailability       Cost-Effectiveness       Metaanalysis       Combined Analysis   News Centre Links General Background Guidelines Journals Search Contact

	© 2003-2004 Boehringer Ingelheim GmbH, Germany. All rights reserved. Imprint | Terms of use.